Histiocytosis: Types, Symptoms, and Treatment Options

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer

Histiocytosis occurs when the body produces too many mutant histiocytes, which are white blood cells that normally help protect the immune system. [1] [2] The excess cells accumulate in the skin, bones, lungs, liver, spleen, or lymph nodes, leading to tissue inflammation and organ dysfunction. [1] The three most common types are Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and Rosai-Dorfman disease (RDD). [1]

What the research says

• Longer treatment improved outcomes in multisystem Langerhans cell histiocytosis. In the LCH-III trial, which randomized more than 400 patients, 5-year survival in the highest-risk group (patients with risk-organ involvement) was 84%, compared with 62% and 69% for similar patients in the earlier LCH-I and LCH-II trials, which used 6 months of treatment. In lower-risk patients, 12 months of treatment lowered the 5-year reactivation rate to 37%, versus 54% with 6 months. Adding methotrexate gave no extra benefit (Gadner et al., Blood, 2013). [3]

• Targeted therapy can work when the BRAF V600 mutation is present. In the VE-BASKET study, 26 adults (22 with Erdheim-Chester disease and 4 with LCH) took the BRAF inhibitor vemurafenib. The confirmed response rate was 61.5% (95% CI 40.6% to 79.8%), and 2-year progression-free survival was 86%. All 15 patients scanned with FDG-PET/CT had a metabolic response, including 12 (80%) with a complete metabolic response. Common side effects included joint pain, rash, and fatigue (Diamond et al., JAMA Oncology, 2018). [4]

• The same gene change appears in many cases, which is why targeted drugs are an option. In a series of 127 patients with histiocytoses, tissue from 93 was tested for BRAF. BRAF V600E mutations were found in 13 of 24 (54%) Erdheim-Chester disease samples and 11 of 29 (38%) LCH samples, but in none of the other histiocytoses, including Rosai-Dorfman disease (Haroche et al., Blood, 2012). [5]

Key Takeaways

Understanding Histiocytosis

Histiocytosis represents a diverse collection of rare conditions characterized by the accumulation of abnormal histiocytes. [1] These cells are a type of white blood cell that normally helps the immune system fight infections. When they acquire genetic mutations, they can multiply uncontrollably and gather in various parts of the body, creating lesions that cause inflammation and scarring. [1] [8]

The impact of the disease depends heavily on whether it is a single-system or multisystem condition. Single-system histiocytosis affects only one organ or tissue type, such as the skin or bones. [1] Multisystem histiocytosis involves several organ systems at the same time and needs a more intensive approach to management and care.

A related condition, hemophagocytic lymphohistiocytosis (HLH), is a separate histiocytic disorder in which the immune system becomes overactive.

Common Types of Histiocytosis

Although there are more than 100 subtypes, three forms account for most diagnoses. [1]

Langerhans Cell Histiocytosis (LCH)

LCH is the most frequently diagnosed type and mainly affects children, at roughly 5 to 9 per million children. [1] It involves Langerhans cells, specialized immune cells normally found in the skin. It is often mild, but it can become life-threatening if it spreads to high-risk organs such as the liver, spleen, or bone marrow.

Erdheim-Chester Disease (ECD)

ECD is a rare form that mainly appears in adults. [1] It is known for causing characteristic changes in the long bones of the legs, and it can also affect the heart, lungs, eyes, kidneys, and central nervous system. [1] Typical findings include sclerotic (hardened) bone lesions, central diabetes insipidus, restrictive pericarditis, and scarring around the kidneys. [6] Because it is so rare, specialized centers are often needed for accurate diagnosis and treatment. Read our full guide to Erdheim-Chester disease.

Rosai-Dorfman Disease (RDD)

RDD is best known for significant swelling of the lymph nodes, particularly in the neck. It can also occur outside the lymph nodes (extranodal), appearing in the skin, soft tissues, or upper respiratory tract. [1] It affects both children and adults, and only about 1 in 200,000 people receive this diagnosis. [1] In some people, such as about 40% of those with RDD, the condition improves without treatment. [1] Read our full guide to Rosai-Dorfman disease or learn more about swollen lymph nodes.

Symptoms and Warning Signs

Symptoms vary widely because they depend on where the abnormal cells have accumulated. People often have a mix of general symptoms and site-specific problems.

How Histiocytosis Is Diagnosed

Diagnosis begins with a physical examination and a review of the medical history. [1] Because the symptoms mimic many other conditions, doctors use additional testing to confirm the presence of abnormal histiocytes.

• Imaging scans: FDG PET/CT scans can detect active lesions throughout the body. [1] MRI, CT, and other scans give detailed views of specific organs such as the brain or lungs. [1]

• Laboratory tests: Blood and urine tests check blood cell counts and organ function, and look for markers that point to excess histiocytes in an organ. [1]

• Biopsy: A tissue sample is examined under a microscope. This is the key step in confirming the diagnosis and in finding specific genetic mutations, such as BRAF, that may guide treatment. [1] [5] Pathologists often use a panel of stains (for example CD1a, langerin, and BRAF V600E) to tell the types apart, and ECD also requires confirmation of an activating mutation in the MAPK pathway. [7]

• Liquid biopsy: If tissue cannot be reached, doctors may test genetic material in the blood instead. [1]

Treatment and Management Strategies

Treatment plans are highly personalized. They take into account the type of histiocytosis, how widespread it is, and the person's overall health.

Observation and Surgery

For mild, single-system cases that do not cause significant symptoms, a "watch and wait" approach may be used. [1] If the histiocytes are limited to one accessible area, surgical removal of the lesion can sometimes cure the condition. [1]

Medical Therapies

When the disease is more widespread, systemic treatments are needed to control cell growth and reduce inflammation. [1]

1. Chemotherapy: Uses medications to destroy abnormal histiocytes. In multisystem LCH, vinblastine with prednisone is a standard combination. [3]

2. Corticosteroids: Drugs such as prednisone manage inflammation and are often paired with other treatments. [1]

3. Targeted therapy: Many cases carry a specific gene mutation (like BRAF). BRAF inhibitors such as vemurafenib and dabrafenib, and MEK inhibitors such as cobimetinib (approved for adults), block the affected pathway to slow or stop the disease. [4] [8]

4. Immunotherapy: Helps the immune system identify and destroy abnormal cells. [1]

5. Radiation therapy: Used to treat specific painful bone lesions or to shrink tumors that are causing immediate problems. [1]

Conclusion

Histiocytosis is a complex and rare group of disorders, but advances in genetic research have improved the outlook for many patients. By identifying specific mutations and using targeted therapies, healthcare providers can now offer more effective and less toxic treatment options. Early diagnosis and a multidisciplinary approach are key to managing the disease and keeping a good quality of life.

Frequently Asked Questions

Is histiocytosis a type of cancer?

It depends on the definition. Cleveland Clinic says histiocytosis isn't a cancer but may behave like one [1], while the World Health Organization classifies LCH, ECD, and RDD as histiocytic neoplasms because of cancer-driving gene mutations. [2] Hematologists and oncologists usually manage it.

Is histiocytosis contagious?

No, it is not an infectious disease and cannot be passed from person to person.

What is the most common type of histiocytosis?

Langerhans cell histiocytosis (LCH) is the most common form. [1]

Who is most affected by LCH?

Children are the most commonly affected group, at roughly 5 to 9 per million children. [1]

Does histiocytosis run in families?

Most cases are sporadic and not directly inherited, though genetic mutations play a role.

Can adults get LCH?

Yes. LCH is more common in children, but it can occur at any age.

What are histiocytes?

They are a type of white blood cell that belongs to the immune system. [1]

How rare is Erdheim-Chester disease?

It is rare and mainly affects adults [1], which is why diagnosis often involves specialized centers.

What causes the lymph node swelling in Rosai-Dorfman disease?

A buildup of histiocytes inside the nodes.

Can histiocytosis affect the brain?

Yes, it can involve the central nervous system, leading to balance and coordination issues. [1]

What is a liquid biopsy?

A test that looks for genetic material from the disease in the blood instead of taking a tissue sample. It may be used when tissue cannot be reached. [1]

Are there any specific diets for histiocytosis?

There is no specific diet, but a healthy, balanced diet supports overall health.

Can histiocytosis go away on its own?

Some mild, localized cases may resolve without treatment. LCH often does in children when it affects only one part of the body, and about 40% of people with RDD improve without treatment. [1] Medical monitoring is still required.

What is the BRAF mutation?

A specific genetic change found in many people with histiocytosis that can be treated with targeted drugs. [4] [5]

How long does chemotherapy for histiocytosis last?

The duration varies widely depending on the response and the severity of the disease. In the LCH-III trial, multisystem LCH was treated for 12 months in total. [3]

Is radiation therapy common for this condition?

It is usually reserved for specific, localized problems such as painful bone lesions.

Can histiocytosis cause permanent organ damage?

If left untreated, chronic inflammation can lead to scarring and organ dysfunction. [1]

What is an FDG PET/CT scan?

A specialized scan that uses a radioactive tracer to find active areas of disease.

Does histiocytosis cause hair loss?

The disease itself does not, but some treatments, such as chemotherapy, might.

Can I exercise with histiocytosis?

Generally yes, but check with your doctor first, especially if you have bone involvement.

What is multisystem histiocytosis?

A form of the disease that involves two or more different organ systems. [1]

What are "high-risk" organs?

The liver, spleen, and bone marrow are considered high-risk in LCH.

Is there a cure for Erdheim-Chester disease?

ECD is often a long-term condition, but many people achieve lasting control with targeted therapy. [1] [4]

Can histiocytosis affect the eyes?

Yes, it can cause bulging eyes (proptosis) or vision changes. [1]

What is the retroperitoneum?

The area behind the abdomen where histiocytes can sometimes accumulate. [1]

Do all patients need chemotherapy?

No. Some people only need surgery, targeted therapy, or observation. [1]

What is prednisone used for in histiocytosis?

It is a corticosteroid used to reduce inflammation. [1]

Can histiocytosis cause skin growths?

Yes, particularly on the eyelids, or as rashes. [1]

Is histiocytosis more common in boys or girls?

LCH is slightly more common in boys, but overall the difference is small.

What is the age range for Rosai-Dorfman disease?

It mostly affects children and young adults, but it can occur at any age.

Can histiocytosis affect the heart?

Yes, particularly in Erdheim-Chester disease. [1]

What are the symptoms of lung involvement?

Cough, chest pain, and shortness of breath.

Does histiocytosis cause bone fractures?

The lesions can weaken bones, making them more susceptible to fractures.

How often are follow-up visits needed?

Usually every few months at first, then less often once the disease is in remission.

What is immunotherapy?

A treatment that helps the body's own immune system fight the disease.

Can histiocytosis affect the liver?

Yes, and liver involvement is considered a high-risk feature in children.

What is the survival rate for histiocytosis?

The outlook depends on the type and the organs involved. Single-system disease often has an excellent outlook, while multisystem disease with risk-organ involvement is more serious: in the LCH-III trial, 5-year survival in that group was 84%. [3]

Can the disease return after treatment?

Yes, recurrence is possible, which is why long-term follow-up is necessary. [1] [3]

What is the difference between classical and extranodal RDD?

Classical RDD affects the lymph nodes. Extranodal RDD affects other tissues, such as the skin or bone.

Does histiocytosis cause excessive thirst?

Yes, if it affects the pituitary gland, leading to diabetes insipidus.

What is diabetes insipidus in this context?

A condition in which the body cannot balance water levels, causing extreme thirst and frequent urination. Read more about diabetes insipidus.

Can histiocytosis affect the teeth?

Yes, bone lesions in the jaw can lead to "floating teeth" or tooth loss.

Is there a support group for histiocytosis?

Yes, organizations such as the Histiocytosis Association provide support and resources.

What is the role of a hematologist?

A doctor who specializes in blood disorders and often leads the treatment team.

Can histiocytosis be diagnosed during pregnancy?

Information is limited, so any pregnancy involving histiocytosis should be managed by a specialized team.

What is the main goal of treatment?

To achieve remission and prevent organ damage.

Do genetic mutations mean it's hereditary?

No. These are usually "somatic" mutations that occur in specific cells during life. [8]

Can histiocytosis cause night sweats?

Night sweats are not among the most commonly listed symptoms, but fever, fatigue, and weight loss can occur. Tell your doctor about any unexplained symptom.

What is the impact of histiocytosis on growth in children?

It can sometimes affect growth if the endocrine system is involved.

Where can I find more information?

Speak with a specialist at a major medical center, and visit the Histiocytosis Association for patient resources.

Related Reading

Erdheim-Chester Disease (ECD): Symptoms, Causes, Diagnosis, Treatment and Outlook — What You Need to Know explains a rare histiocytosis that affects bones and organs.

Rosai-Dorfman Disease: Symptoms, Causes, and Management explains a rare histiocytic disorder causing swollen lymph nodes.

Hemophagocytic Lymphohistiocytosis (HLH): Symptoms, Causes, and Care explains a serious immune overactivation disorder involving histiocytes.

Diabetes Insipidus: Symptoms, Types, Causes & Treatment — Complete Guide explains the thirst and urination disorder some histiocytosis patients develop.

References

1. Cleveland Clinic. What Is Histiocytosis? Cleveland Clinic. Last updated August 1, 2023. https://my.clevelandclinic.org/health/diseases/25171-histiocytosis

2. Histiocytosis Association. Overview of Histiocytic Disorders. Histiocytosis Association. Last updated August 17, 2026. https://histio.org/histiocytic-disorders/

3. Gadner H, Minkov M, Grois N, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121(25):5006-5014. PMID 23589673. https://doi.org/10.1182/blood-2012-09-455774

4. Diamond EL, Subbiah V, Lockhart AC, et al. Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncology. 2018;4(3):384-388. PMID 29188284. https://doi.org/10.1001/jamaoncol.2017.5029

5. Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700-2703. PMID 22879539. https://doi.org/10.1182/blood-2012-05-430140

6. Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929-1945. PMID 32187362. https://doi.org/10.1182/blood.2019003507

7. Rech KL, He R. Challenges in the histopathologic diagnosis of histiocytic neoplasms. Journal of the National Comprehensive Cancer Network. 2021;19(11):1305-1311. PMID 34781270. https://doi.org/10.6004/jnccn.2021.7098

8. Koh KN, Yoon SH, Kang SH, et al. Advancements in the understanding and management of histiocytic neoplasms. Blood Research. 2024;59(1):22. PMID 38963520. https://doi.org/10.1007/s44313-024-00022-w

Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.